Major triple yang refers to hepatitis B major triple yang. In hepatitis B major triple yang, those who have abnormal liver function or have liver tissue damage need to be treated, but virus carriers usually do not need to be treated, and regular rechecks are sufficient. Hepatitis B triple positive refers to patients who are found to be positive for Hepatitis B surface antigen, Hepatitis B e antigen, and Hepatitis B core antibody during the Hepatitis B two-to-half test. When the patient is clear that the liver function is normal and there is no damage to the liver, treatment is generally not required, but regular review is needed. For patients with hepatitis B teratitis B who have abnormal liver function or tissue damage in the liver, they can be treated with nucleoside analogs such as entecavir and tenofovir, and interferon-alpha such as ordinary interferon and polyethylene glycol interferon as prescribed by the doctor. Patients with abnormal liver function can also use hepatoprotective drugs, such as reduced glutathione and ursodeoxycholic acid. It is recommended that patients with triple III Yang adjust their mentality, consult the doctor in time, cooperate with the doctor’s treatment, and not use drugs or prescriptions on their own to prevent aggravation of the condition.